| Literature DB >> 34335381 |
Yang Li1,2, Aiwen Wang1,2, Yalin Wu3, Nana Han1,2, Huiming Huang1,2.
Abstract
BACKGROUND: The coronavirus disease (COVID-19) pandemic has been spreading and brought unprecedented psychological pressure on people across the entire globe since December 2019.Entities:
Keywords: COVID-19; anxiety; college students; depression; mental health; meta-analysis
Year: 2021 PMID: 34335381 PMCID: PMC8316976 DOI: 10.3389/fpsyg.2021.669119
Source DB: PubMed Journal: Front Psychol ISSN: 1664-1078
FIGURE 1A flowchart describing the search strategy and selection of studies, using the preferred reporting items for systematic reviews and meta-analyses (PRISMA).
Characteristics of the studies and methodological quality.
| Number | Author location | Survey time | Sample male/female | Age1 | Educational level | Majors | Instrument | Main outcomes | JBI evaluation results |
| 1 | Feb. 13th–Feb. 22nd | 323489 130516/192973 | 19−22 | Undergraduate | NM | PHQ-9, RESEs | B, D, L, H | Include | |
| 2 | NM | 7143 2168/4975 | NM | Undergraduate | NM | GAD-7 | A | Include | |
| 3 | Feb. 10th–Feb. 17th | 3611 1454/2157 | 18−24 | Undergraduate | Arts Sciences | SAS | A, F, I, N | Include | |
| 4 | Feb. 23rd–Apr. 2nd | 217 90/127 | 18−27 | Undergraduate Postgraduate | NM | PHQ-9, GAD-7 | A, D | Include | |
| 5 | NM | 291 72/219 | 19.07 ± 1,7 | NM | Social Sciences2 Health Sciences | GAD-7 | A, E | Include | |
| 6 | Mar.30th–Apr. 9th | 863 98/765 | NM | Graduate student | NM | PHQ-9 | D | Include | |
| 7 | Feb. 4th–Feb. 12th | 933 279/654 | Over 17 | Undergraduate Postgraduate | NM | PHQ-9, GAD-7 | A, D | Include | |
| 8 | Mar. 22nd–Mar.28th | 1165 538/627 | NM | Undergraduate Postgraduate | NM | PHQ-9, GAD-7 | A, D | Include | |
| 9 | Feb. 12th–Feb. 17th | 2038 755/1283 | 20.56 ± 1.9 | NM | NM | PHQ-9, PTGI, PCL Z-SAS | A, D, G, J | Include | |
| 10 | Feb. 20th–Feb. 27th | 2485 960/1525 | 19.81 ± 1.55 | Undergraduate | NM | PHQ-9, PCL-C | D, G | Include | |
| 11 | Jan. 31st–Feb. 5th | 44447 20217/24230 | 21.0 ± 2.4 | Undergraduate Postgraduate | NM | PHQ-9 SAS | A, D | Include | |
| 12 | Apr. 24th–Jun. 5th | 477 NM | 20.7 | NM | NM | GAD-2, PHQ-2 | A, D, K | Include | |
| 13 | Zhao et al. | Mar. 23rd–Apr.20th | 821 305/516 | 23.08 ± 4.78 | Undergraduate Postgraduate | NM | PHQ-9 | A | Include |
| 14 | May. 4th–May.19th | 2031 779/1252 | 22.88 ± 5.22 | Undergraduate Postgraduate | NM | PHQ-9 GAD-7 | A, D, H | Include | |
| 15 | May. 1st – May. 24th | 365 36/329 | 23.22 ± 6.16 | Undergraduate Other | NM | DASS-21 (Spanish) | A | Include | |
| 16 | May. 6th–May. 12th | 476 320/156 | Over 17 | NM | NM | PHQ-9 GAD-7 | A, D | Include | |
| 17 | Apr. 8th–May. 2nd | 1821 493/1301 | 26.17 | Undergraduate Postgraduate | NM | PHQ-9, GAD-7 | A, D | Include | |
| 18 | Apr. 20th–Apr. 27th | 520 201/319 | 21.03 ± 2.66 | Undergraduate | NM | DASS-21 | A, D | Include | |
| 19 | Apr. 3rd–Apr. 14th | 2429 753/1676 | 26.40 ± 5.40 | Undergraduate Postgraduate | NM | GAD-7 | A | Include | |
| 20 | Jan. 31st–Feb. 3rd | 3881 1434/2447 | Over 18 | NM | NM | PHQ-9, GAD-7 | A, D | Include | |
| 21 | Feb. 13th–Feb.16th | 430 139/291 | 18−25 | NM | Medical Specialty Non-Medical Specialty | SAS, SDS | A, D | Include | |
| 22 | Feb. 27th–Feb. 29th | 399 162/237 | NM | NM | Medical Specialty | PHQ-9, GAD-7 | A, D | Include | |
| 23 | Mar. 17th–Mar. 19th | 266 76/190 | NM | Undergraduate Postgraduate | Medical Specialty | DASS (China) | A, D | Include | |
| 24 | Feb.27th–Feb. 28th | 84 52/32 | 19.9 ± 2.21 | Undergraduate | Non-Medical Specialty | PHQ-9, GAD-7 | A, D | Include | |
| 25 | Feb. 16th–Feb. 20th | 1196 402/794 | Over 17 | Undergraduate | NM | SAS | A, D | Include | |
| 26 | NM | 370 77/289 | 25.2 ± 3.1 | NM | NM | FCV-19s | F | Include | |
| 27 | NM | 304167 122102/182065 | NM | NM | NM | IES-6 | E, G, O, P | Include |
FIGURE 2Meta-analysis of depression in college students during the COVID-19 pandemic.
Subgroup analysis of depression in college students during the COVID-19 pandemic.
| Subgroup | Researches (Num) | Heterogeneity | Model | Meta-analysis | |
| I-square | Effect Size (95% CI) | ||||
| China nations | 10 | 98.8% | <0.05 | REM | 0.26 (0.21–0.30) |
| Non-China nations | 8 | 99.5% | <0.05 | REM | 0.60 (0.46–0.74) |
| Male | 5 | 72.6% | <0.05 | REM | 0.22 (0.17–0.28) |
| Female | 5 | 84.3% | <0.05 | REM | 0.25 (0.19–0.32) |
| Undergraduate | 7 | 99.1% | <0.05 | REM | 0.23 (0.16–0.30) |
| Postgraduate | 5 | 96.4% | <0.05 | REM | 0.22 (0.14–0.31) |
| Medicine | 5 | 87.6% | <0.05 | REM | 0.24 (0.19–0.30) |
| Non- Medicine | 2 | 78.4% | <0.05 | REM | 0.18 (0.06–0.31) |
| By Mar. 1st | 8 | 98.7% | <0.05 | REM | 0.21 (0.16–0.25) |
| After Mar. 1st | 10 | 99.5% | <0.05 | REM | 0.54 (0.40–0.67) |
FIGURE 3Meta-analysis of anxiety in college students during the COVID-19 pandemic.
Subgroup analysis of anxiety in college students during the COVID-19 pandemic.
| Subgroup | Researches (Num) | Heterogeneity | Model | Meta-analysis | |
| I-square | effect size (95% CI) | ||||
| China nations | 12 | 99.5% | <0.05 | REM | 0.20 (0.14–0.26) |
| Non-China nations | 8 | 99.6% | <0.05 | REM | 0.60 (0.46–0.74) |
| Male | 7 | 99.2% | <0.05 | REM | 0.27 (0.12–0.42) |
| Female | 8 | 99.1% | <0.05 | REM | 0.33 (0.22–0.43) |
| Undergraduate | 10 | 99.6% | <0.05 | REM | 0.23 (0.16–0.30) |
| Postgraduate | 5 | 96.3% | <0.05 | REM | 0.17 (0.09–0.25) |
| Medicine | 5 | 18.9% | 0.294 | REM | 0.17 (0.15–0.19) |
| Non- Medicine | 3 | 46.9% | 0.152 | REM | 0.16 (0.12–0.20) |
| By Mar. 1st | 9 | 99.4% | <0.05 | REM | 0.19 (0.13–0.25) |
| After Mar. 1st | 8 | 99.9 | <0.05 | REM | 0.37 (0.26–0.48) |
Sensitivity analysis.
| Excluding | Effect size | 95% CI |
| Liu et al. | 0.39 | 0.27−0.51 |
| Enkeleint A. Mechili et al. | 0.38 | 0.26−0.50 |
| Xiao et al. | 0.40 | 0.28−0.52 |
| Abdallah Y. Naser et al. | 0.39 | 0.26−0.52 |
| Chi et al. | 0.40 | 0.27−0.53 |
| Tang et al. | 0.41 | 0.27−0.55 |
| Wang et al. | 0.40 | 0.26−0.54 |
| Gilbert Gonzales et al. | 0.38 | 0.26−0.50 |
| Zhao et al. | 0.38 | 0.26−0.50 |
| Wang et al. | 0.37 | 0.27−0.47 |
| Islam. MdAkhtarul et a | 0.36 | 0.24−0.48 |
| Rudenstine et al | 0.36 | 0.26−0.36 |
| Fawaz. Mirna et al. | 0.40 | 0.26−0.54 |
| Chang et al. | 0.40 | 0.27−0.53 |
| Wang et al. | 0.40 | 0.27−0.53 |
| Jiang et al. | 0.40 | 0.27−0.53 |
| Zhan et al. | 0.40 | 0.27−0.53 |
| Yao et al. | 0.40 | 0.28−0.52 |
| Overall | 0.39 | 0.27−0.51 |
| Cao et al. | 0.36 | 0.25−0.47 |
| Wang et al. | 0.37 | 0.26−0.48 |
| Liu et al. | 0.36 | 0.26−0.46 |
| Xiao et al. | 0.37 | 0.27−0.47 |
| Abdallah Y. Naser et al. | 0.37 | 0.27−0.47 |
| Chi et al. | 0.37 | 0.26−0.48 |
| Wang et al. | 0.37 | 0.27−0.47 |
| Gilbert Gonzales et al. | 0.34 | 0.24−0.44 |
| wang et al. | 0.34 | 0.25−0.43 |
| Islam. MdAkhtarul | 0.33 | 0.24−0.42 |
| Díaz-Jiménez. R. M. | 0.34 | 0.24−0.44 |
| Rudenstine et a | 0.34 | 0.25−0.43 |
| Fawaz. Mirna et al | 0.36 | 0.25−0.47 |
| Dratva. Julia et al | 0.35 | 0.25−0.45 |
| Chang et al. | 0.36 | 0.25−0.47 |
| Wang et al. | 0.36 | 0.26−0.46 |
| Jiang et al. | 0.35 | 0.25−0.45 |
| Zhan et al. | 0.37 | 0.27−0.47 |
| Yao et al. | 0.37 | 0.27−0.47 |
| Wu et al | 0.37 | 0.27−0.47 |
| Overall | 0.36 | 0.26−0.46 |
FIGURE 4A funnel plot (A) A funnel plot of depression prevalence; (B) A funnel plot of anxiety prevalence.
A list of investigation of psychological problems.
| Psychological problems | Researches | Participants | Patients | Analytical method | Effect size |
| Depression | 19 | 386,806 | 37,714 | 1Meta-analysis | 39% (95% CI: 27–51%) |
| Anxiety | 21 | 74,203 | 13,746 | 2Meta-analysis | 36% (95% CI: 26–46%) |
| Stress | 4 | 305,244 | 56,239 | NMA | 6.39–21.65% |
| PTSD | 3 | 308,690 | 99,961 | NMA | 2.70–32.74% |
| Suicide | 2 | 325,520 | 23,299 | NMA | 7.09–18.02% |
| Fear | 2 | 3,981 | 452 | NMA | 12.52% |
| Panic | 1 | 3,611 | 737 | NMA | 20.41% |
| PTG | 1 | 2,038 | 1,363 | NMA | 66.88% |
| PD | 1 | 477 | 290 | NMA | 60.80% |
| RESE | 1 | 323,489 | NM | NMA | 3None |
| Somatic Symptom | 1 | 84 | 9 | NMA | 10.71% |
| Tired | 1 | 3,611 | 731 | NMA | 20.24% |
| Sleeplessness | 1 | 304,167 | 9,752 | NMA | 3.21% |
| Self-perceived Mental Health | 1 | 304,167 | 1,565 | NMA | 0.51% |